Angelman syndrome: review of clinical and molecular aspects
Top Cited Papers
Open Access
- 1 May 2014
- journal article
- review article
- Published by Taylor & Francis Ltd in The Application of Clinical Genetics
- Vol. 7, 93-104
- https://doi.org/10.2147/tacg.s57386
Abstract
Angelman syndrome: review of clinical and molecular aspects Lynne M Bird1Department of Pediatrics, University of California, Division of Genetics, Rady Children’s Hospital, San Diego, California, USA “Angelman syndrome” (AS) is a neurodevelopmental disorder whose main features are intellectual disability, lack of speech, seizures, and a characteristic behavioral profile. The behavioral features of AS include a happy demeanor, easily provoked laughter, short attention span, hypermotoric behavior, mouthing of objects, sleep disturbance, and an affinity for water. Microcephaly and subtle dysmorphic features, as well as ataxia and other movement disturbances, are additional features seen in most affected individuals. AS is due to deficient expression of the ubiquitin protein ligase E3A (UBE3A) gene, which displays paternal imprinting. There are four molecular classes of AS, and some genotype–phenotype correlations have emerged. Much remains to be understood regarding how insufficiency of E6-AP, the protein product of UBE3A, results in the observed neurodevelopmental deficits. Studies of mouse models of AS have implicated UBE3A in experience-dependent synaptic remodeling.Keywords: Angelman syndrome, chromosome 15q11-13, UBE3A, imprintingKeywords
This publication has 101 references indexed in Scilit:
- Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndromeNeurobiology of Disease, 2010
- Double‐blind therapeutic trial in Angelman syndrome using betaine and folic acidAmerican Journal of Medical Genetics Part A, 2010
- The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13Neurobiology of Disease, 2010
- The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating ArcCell, 2010
- Angelman syndrome (AS, MIM 105830)European Journal of Human Genetics, 2009
- Angelman syndrome 2005: Updated consensus for diagnostic criteriaAmerican Journal of Medical Genetics Part A, 2006
- Angelman syndrome: Mimicking conditions and phenotypesAmerican Journal of Medical Genetics, 2001
- De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndromeNature Genetics, 1997
- UBE3A/E6-AP mutations cause Angelman syndromeNature Genetics, 1997
- Inherited microdeletions in the Angelman and Prader–Willi syndromes define an imprinting centre on human chromosome 15Nature Genetics, 1995